Close
CDMO Safety Testing 2026
Novotech

Schreiner MediPharm’s High-Tech Digital Adherence Monitoring Solution Wins FINAT Award

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, won a prestigious award for its Smart Blister Card from the European Association of the Self-Adhesive Label Industry (FINAT), which recognizes the industryโ€™s best products. The Smart Blister Card, which extends standard multi-dose blister packs by a digital adherence monitoring tool enabling tracking of medication intake in real time, received the top honor in the โ€œInnovation & Electronic Printing โ€“ Electronic Devicesโ€ category.

In the case of polypharmaceutical applications (permanent therapies involving the simultaneous prescription of several medications), pills are frequently filled into standard blister packs by hospital and large pharmacies so that patients can take them according to their medication plans. However, physicians and pharmacies typically have no way of tracking whether and when patients have taken their medicines. Schreiner MediPharmโ€™s Smart Blister Card tackles this challenge by enabling digital medication adherence monitoring.

Integrated into the Smart Blister Card are conductive lines combined with an electronic unit. Once the patient pushes a tablet out of a cavity, data is generated in real time and includes information such as the exact time of pill removal, the respective cavity, and the dose it contains. The data is then stored in the Smart Blister Card and transmitted to a database via a smartphone app or a reader using NFC or Bluetooth technology.

For physicians and pharmacists, the handling of the Smart Blister Card is both convenient and flexible. After filling and sealing the blister pack, the Smart Blister Card is simply attached to the back of the pack without impairing the filling process. The technology can be inconspicuously integrated into the packaging design, and the marking of each cavity remains clearly visible. In addition, a temperature monitoring feature for sensitive ingredients is an available option.

The Smart Blister Card is suitable for nearly all existing multi-dose and single-dose blister packs. Patients can take their pills as usual because the cavities can be pushed through as easily as before. Additionally, smartphone apps can provide patients with digital self-monitoring support and even enable a reminder function to comply with their medication plan. Thus, Schreiner MediPharmโ€™s Smart Blister Card helps enhance therapeutic success in polypharmaceutical applications.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป